» Articles » PMID: 38467769

Mutation Order in Acute Myeloid Leukemia Identifies Uncommon Patterns of Evolution and Illuminates Phenotypic Heterogeneity

Abstract

Acute myeloid leukemia (AML) has a poor prognosis and a heterogeneous mutation landscape. Although common mutations are well-studied, little research has characterized how the sequence of mutations relates to clinical features. Using published, single-cell DNA sequencing data from three institutions, we compared clonal evolution patterns in AML to patient characteristics, disease phenotype, and outcomes. Mutation trees, which represent the order of select mutations, were created for 207 patients from targeted panel sequencing data using 1 639 162 cells, 823 mutations, and 275 samples. In 224 distinct orderings of mutated genes, mutations related to DNA methylation typically preceded those related to cell signaling, but signaling-first cases did occur, and had higher peripheral cell counts, increased signaling mutation homozygosity, and younger patient age. Serial sample analysis suggested that NPM1 and DNA methylation mutations provide an advantage to signaling mutations in AML. Interestingly, WT1 mutation evolution shared features with signaling mutations, such as WT1-early being proliferative and occurring in younger individuals, trends that remained in multivariable regression. Some mutation orderings had a worse prognosis, but this was mediated by unfavorable mutations, not mutation order. These findings add a dimension to the mutation landscape of AML, identifying uncommon patterns of leukemogenesis and shedding light on heterogeneous phenotypes.

Citing Articles

LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia.

Xu H, Chen D, Lu J, Wang L, Chen F, Zhong L Discov Oncol. 2025; 16(1):305.

PMID: 40072762 PMC: 11904058. DOI: 10.1007/s12672-025-02082-5.


Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic system.

Jang G, Park R, Esteva E, Hsu P, Feng J, Upadhaya S J Exp Med. 2025; 222(6).

PMID: 40072317 PMC: 11899982. DOI: 10.1084/jem.20240587.


The synergistic effect of c-Myb hyperactivation and Pu.1 deficiency induces Pelger-Huët anomaly and promotes sAML.

Xu S, Hong J, Dongye M, Lin J, Xue R, Huang Z Proc Natl Acad Sci U S A. 2025; 122(9):e2416121122.

PMID: 40020188 PMC: 11892618. DOI: 10.1073/pnas.2416121122.


Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution.

Poon G, Vedi A, Sanders M, Laurenti E, Valk P, Blundell J Cell Genom. 2025; 5(2):100744.

PMID: 39842433 PMC: 11872528. DOI: 10.1016/j.xgen.2024.100744.


Orchard: Building large cancer phylogenies using stochastic combinatorial search.

Kulman E, Kuang R, Morris Q PLoS Comput Biol. 2025; 20(12):e1012653.

PMID: 39775053 PMC: 11723595. DOI: 10.1371/journal.pcbi.1012653.

References
1.
Fowler J, King C, Bryant C, Hall M, Sood R, Ong S . Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site. Cancer Discov. 2020; 11(2):340-361. PMC: 7116717. DOI: 10.1158/2159-8290.CD-20-1092. View

2.
Benard B, Leak L, Azizi A, Thomas D, Gentles A, Majeti R . Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia. Nat Commun. 2021; 12(1):7244. PMC: 8669028. DOI: 10.1038/s41467-021-27472-5. View

3.
Corces-Zimmerman M, Hong W, Weissman I, Medeiros B, Majeti R . Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A. 2014; 111(7):2548-53. PMC: 3932921. DOI: 10.1073/pnas.1324297111. View

4.
Mims A, Kohlschmidt J, Borate U, Blachly J, Orwick S, Eisfeld A . A precision medicine classification for treatment of acute myeloid leukemia in older patients. J Hematol Oncol. 2021; 14(1):96. PMC: 8220739. DOI: 10.1186/s13045-021-01110-5. View

5.
Whitman S, Archer K, Feng L, Baldus C, Becknell B, Carlson B . Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res. 2001; 61(19):7233-9. View